NAS:MGLN (USA) Also trade in: Germany

Magellan Health Inc

$ 64.63 -1.61 (-2.43%)
On watch
Volume: 129,796 Avg Vol (1m): 300,466
Market Cap $: 1.58 Bil Enterprise Value $: 1.68 Bil
P/E (TTM): 126.73 P/B: 1.16
Earnings Power Value 13.36
Net Current Asset Value -6.64
Tangible Book 5
Projected FCF 92.51
Median P/S Value 130.1
Graham Number 7.58
Peter Lynch Value 4.38
DCF (FCF Based) 50.59
DCF (Earnings Based) 5.46
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.86
Cash-To-Debt range over the past 10 years
Min: 0.02, Med: 1.52, Max: 27173.79
Current: 0.86
0.02
27173.79
Equity-to-Asset 0.43
Equity-to-Asset range over the past 10 years
Min: -0.59, Med: 0.53, Max: 0.68
Current: 0.43
-0.59
0.68
Debt-to-Equity 0.55
Debt-to-Equity range over the past 10 years
Min: -1.87, Med: 0.48, Max: 9.54
Current: 0.55
-1.87
9.54
Debt-to-EBITDA 3.58
Debt-to-EBITDA range over the past 10 years
Min: 0, Med: 1.43, Max: 3.58
Current: 3.58
0
3.58
Interest Coverage 1.48
Interest Coverage range over the past 10 years
Min: 1.48, Med: 36.1, Max: 99.13
Current: 1.48
1.48
99.13
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.88
DISTRESS
GREY
SAFE
WACC vs ROIC %
ROIC 1.39%
WACC 4.97%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 0.75
Operating Margin range over the past 10 years
Min: 0.75, Med: 4, Max: 7.46
Current: 0.75
0.75
7.46
Net Margin % 0.18
Net Margin range over the past 10 years
Min: 0.18, Med: 2.82, Max: 4.71
Current: 0.18
0.18
4.71
ROE % 1.01
ROE range over the past 10 years
Min: 1.01, Med: 10.38, Max: 16.22
Current: 1.01
1.01
16.22
ROA % 0.43
ROA range over the past 10 years
Min: 0.43, Med: 5.81, Max: 10.59
Current: 0.43
0.43
10.59
ROC (Joel Greenblatt) % 35.21
ROC (Joel Greenblatt) range over the past 10 years
Min: 35.21, Med: 86.35, Max: 183.36
Current: 35.21
35.21
183.36
3-Year Total Revenue Growth Rate 16.70
3-Year Revenue Growth Rate range over the past 10 years
Min: -10.5, Med: 9.1, Max: 20.2
Current: 18
-10.5
20.2
3-Year Total EBITDA Growth Rate 5.40
3-Year EBITDA Growth Rate range over the past 10 years
Min: -30.9, Med: 8.15, Max: 34.8
Current: 6.5
-30.9
34.8
3-Year EPS w/o NRI Growth Rate -7.10
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: -4.6, Max: 316.8
Current: -7.1
0
316.8

Ratios

Current vs industry vs history
PE Ratio (TTM) 126.73
PE Ratio range over the past 10 years
Min: 8.4, Med: 15.92, Max: 147.83
Current: 126.73
8.4
147.83
PE Ratio without NRI 126.73
PE without NRI range over the past 10 years
Min: 8.4, Med: 15.92, Max: 147.83
Current: 126.73
8.4
147.83
Price-to-Owner-Earnings 17.48
Price-to-Owner-Earnings range over the past 10 years
Min: 4.87, Med: 15.01, Max: 58.02
Current: 17.48
4.87
58.02
PB Ratio 1.16
PB Ratio range over the past 10 years
Min: 1, Med: 1.47, Max: 2.03
Current: 1.16
1
2.03
PS Ratio 0.22
PS Ratio range over the past 10 years
Min: 0.19, Med: 0.44, Max: 0.67
Current: 0.22
0.19
0.67
Price-to-Free-Cash-Flow 13.67
Price-to-Free-Cash-Flow range over the past 10 years
Min: 4.16, Med: 13.15, Max: 176.17
Current: 13.67
4.16
176.17
Price-to-Operating-Cash-Flow 9.05
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 3.71, Med: 8.84, Max: 26.53
Current: 9.05
3.71
26.53
EV-to-EBIT 23.24
EV-to-EBIT range over the past 10 years
Min: 3.6, Med: 7.6, Max: 26.5
Current: 23.24
3.6
26.5
EV-to-EBITDA 8.20
EV-to-EBITDA range over the past 10 years
Min: 2.9, Med: 5.2, Max: 10.9
Current: 8.2
2.9
10.9
EV-to-Revenue 0.23
EV-to-Revenue range over the past 10 years
Min: 0.2, Med: 0.3, Max: 0.5
Current: 0.23
0.2
0.5
PEG Ratio 31.68
PEG Ratio range over the past 10 years
Min: 0.6, Med: 1.77, Max: 94.61
Current: 31.68
0.6
94.61
Shiller PE Ratio 17.41
Shiller PE Ratio range over the past 10 years
Min: 10.25, Med: 19.47, Max: 1224
Current: 17.41
10.25
1224
Current Ratio 1.71
Current Ratio range over the past 10 years
Min: 0.19, Med: 1.72, Max: 2.42
Current: 1.71
0.19
2.42
Quick Ratio 1.66
Quick Ratio range over the past 10 years
Min: 0.19, Med: 1.68, Max: 2.42
Current: 1.66
0.19
2.42
Days Inventory 2.36
Days Inventory range over the past 10 years
Min: 2.1, Med: 4.05, Max: 5.26
Current: 2.36
2.1
5.26
Days Sales Outstanding 40.94
Days Sales Outstanding range over the past 10 years
Min: 13.15, Med: 29.27, Max: 45.79
Current: 40.94
13.15
45.79
Days Payable 3.91
Days Payable range over the past 10 years
Min: 2.11, Med: 4.8, Max: 7.62
Current: 3.91
2.11
7.62

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate 1.70
3-Year Share Buyback Rate range over the past 10 years
Min: -7.2, Med: -0.4, Max: 11
Current: 1.7
-7.2
11

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 12.92
Price-to-Tangible-Book range over the past 10 years
Min: 2.3, Med: 3.85, Max: 1206.88
Current: 12.92
2.3
1206.88
Price-to-Projected-FCF 0.70
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.38, Med: 0.69, Max: 1.89
Current: 0.7
0.38
1.89
Price-to-DCF (Earnings Based) 11.84
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 1.59, Med: 2.11, Max: 13.6
Current: 11.84
1.59
13.6
Price-to-Median-PS-Value 0.50
Price-to-Median-PS-Value range over the past 10 years
Min: 0.44, Med: 1.13, Max: 2.34
Current: 0.5
0.44
2.34
Price-to-Peter-Lynch-Fair-Value 14.76
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.61, Med: 1.11, Max: 16.95
Current: 14.76
0.61
16.95
Price-to-Graham-Number 8.52
Price-to-Graham-Number range over the past 10 years
Min: 0.93, Med: 1.78, Max: 34.12
Current: 8.52
0.93
34.12
Earnings Yield (Joel Greenblatt) % 4.30
Earnings Yield (Greenblatt) range over the past 10 years
Min: 3.8, Med: 13.2, Max: 28.1
Current: 4.3
3.8
28.1
Forward Rate of Return (Yacktman) % 12.70
Forward Rate of Return range over the past 10 years
Min: -3.4, Med: 12.2, Max: 25.8
Current: 12.7
-3.4
25.8

» MGLN's 30-Y Financials

Financials (Next Earnings Date: 2019-11-07)

» Interactive Chart

Peter Lynch Chart

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:MGLN

Business Description

Industry Health Care Plans » Health Care Plans    NAICS : 622310    SIC : 8069
Compare BSP:QUAL3 OSTO:MCOV B XPAR:GDS BSP:ODPV3 NAS:HIIQ ATH:IATR ROCO:6665 ASX:ONT TSXV:META MIL:HI OSTO:FEEL TSXV:NXG WAR:DAM BSP:GNDI3 NYSE:MOH NYSE:WCG NYSE:CNC NYSE:HUM NYSE:CI NYSE:CVS
Traded in other countries MAH1.Germany
Address 4800 Scottsdale Road, Suite 4400, Scottsdale, AZ, USA, 85251
Magellan Health provides healthcare management services to health plans and other managed care organizations, employers, labor unions, United States government agencies, and third party administrators. The firm operates in two segments: Healthcare segment and Pharmacy Management segment. The Healthcare business manages behavioral healthcare services and employee assistance program services, as well as specialty areas like diagnostic imaging. The Pharmacy Management segment includes pharmacy benefit management (PBM) services, pharmacy benefit administration for Medicaid and other government sponsored programs, pharmaceutical dispensing operations, and clinical and formulary management programs. The Healthcare business generates the majority of revenue.

More Statistics

Revenue (TTM) (Mil) $ 7,225.98
EPS (TTM) $ 0.51
Beta 0.74
Volatility % 30.89
52-Week Range $ 51.88 - 77.1
Shares Outstanding (Mil) 24.4

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy N